HCA Healthcare (HCA) is America’s largest health system as measured by net patient revenue of nearly $50 billion. Headquartered in Nashville, Tennessee, they manage 185 hospitals and 119 freestanding surgery centers, including surgery centers, freestanding ERs, urgent care centers, and physician clinics in the United States and United Kingdom. Overall, it manages 1,800 sites of care. Publicly traded, the company ranks 67th in terms of largest corporations in America. By 2018, HCA had 50 hospitals and 31 surgery centers in Florida. In Texas, it had 53 hospitals by 2018—and in Tennessee, it operated 13 hospitals by 2019. HCA employs over 38,000 active medical staff. By 2010, Sarah Cannon Research Institute became the clinical trials research arm of HCA.
HCA Healthcare (HCA) Clinical Excellence
HCA represents a large, robust expert network of care. From conducting large-scale clinical research with partners such as Harvard Pilgrim Institute and the CDC, to using data from more than 26 million patient experiences per year, HCA drives collaboration with physicians to discovery and deliver predictive, precise and personalized medicine for their patients.
From creating a new standard of care (REDUCE MRSA) to leveraging big data, to partnering with clinical groups such as Sarah Cannon for HCA’s cancer institute, HCA has been a clinical trial leader in approximately 80% of approved cancer therapies over the past 10 years—all in the pursuit to help benefit more patients. HCA utilizes recruiters who represent physicians from each therapeutic area.
Clinical Trials through Sarah Cannon Research Institute
The Sarah Cannon Research Institute became the research arm of HCA in 2010, according to a Sarah Cannon history timeline. Since then, the cancer research initiatives are embedded in HCA healthcare system services. Last year, over 500 clinical trials were offered to HCA Healthcare patients, which also included 300 ‘first-to-man’ new therapies. The scale and reach is impressive.
The HCA Midwest Health Clinical Research Program was established in 2008 for the purposes of patient care support through availability of clinical trials in the Kansas City metropolitan area. Clinical trials are conducted by well-trained institutional affiliated researchers. The program offers services at Belton Regional Medical Center, Centerpoint Medical Center and Lee’s Summit Medical Center, Menorah Medical Center, Overland Park Regional Medical Center and Research Medical Center.
Clinical Trials are conducted by the principal investigator and reviewed by the HCA Midwest Health System’s Institutional Review Board and guided by standards, such as the Common Rule 45 CFR 46 and 21 CFR 56.
Cancer Trials in the Midwest
The Clinical Research program in the Midwest includes 5 full-time coordinators specializing in Oncology, Cardiology and Neuroscience therapeutic lines as well as a full-time regulatory specialist, financial specialist, and others. The Clinical research program is available through the Kansas City Clinical Oncology Program (KCCOP), Sarah Cannon Research Institute, and various pharmaceutical partners.
HCA Midwest Health currently has 33 clinical cancer trials available. The Clinical research program offers constantly new ways to prevent, detect, or treat disease.
Call to Action: HCA’s clinical trials are managed through its clinical research arm Sarah Cannon Research Institute, a global leader in cancer research and conducting cancer trials. They have been serving patients in the community for over a quarter century. They offer physicians and their patients more than 200+ unique agents through trials each year. Patients can directly search for trials on their website. For those interested in cancer research in HCA hospitals, use the Sarah Cannon website.